Researching TrumpRx GLP-1 Compounds? QSC supplies the full GLP-1 research class — including Retatrutide and Orforglipron, unavailable through TrumpRx
TrumpRx provides prescription semaglutide and tirzepatide for clinical use. QSC provides the complete GLP-1 research compound landscape — including next-generation compounds like Retatrutide (−24.2%, Phase 2), Orforglipron, Cagrilintide, and Survodutide — for in vitro laboratory research only.
TrumpRx is a telehealth and compounding pharmacy platform — they prescribe and dispense FDA-regulated GLP-1 medications for patient weight management under physician supervision. QSC is a research compound supplier — we provide verified research-grade compounds for in vitro laboratory research only. If you are a patient seeking GLP-1 treatment, consult a licensed physician. If you are a researcher studying GLP-1 biology, QSC is your source.
Researchers who discover GLP-1 compounds through platforms like TrumpRx often then search for research-grade versions for laboratory work. QSC is the comprehensive research source: the full GLP-1 class including next-generation compounds years ahead of any clinical channel, all at ≥99% HPLC purity with independently verifiable Janoshik COA.
QSC vs TrumpRx: Full Comparison
Different categories, different customers — the table below clarifies what each offers and who each serves.
TrumpRx is a US telehealth and compounding pharmacy platform offering prescription GLP-1 medications — primarily compounded semaglutide and tirzepatide — for weight management. Like Hims, Ro, and similar platforms, TrumpRx operates within the clinical supply chain: they require a physician consultation and dispense FDA-regulated pharmaceutical compounds to patients. QSC is a research compound supplier — an entirely different category serving laboratory researchers, not patients seeking clinical treatment.
What is the difference between TrumpRx and QSC?
TrumpRx is a telehealth platform dispensing prescription GLP-1 medications (compounded semaglutide, tirzepatide) to patients under physician supervision. QSC is a research compound supplier providing research-grade GLP-1 compounds for in vitro laboratory research only. Different categories, different customers: TrumpRx serves patients; QSC serves researchers. The key advantage of QSC for researchers is access to next-generation GLP-1 compounds — Retatrutide, Orforglipron, Cagrilintide, Survodutide — unavailable through any clinical channel including TrumpRx.
Does QSC sell semaglutide and tirzepatide for research?
Yes — QSC stocks research-grade semaglutide and tirzepatide at ≥99% HPLC purity with Janoshik independent COA verification for in vitro laboratory research. QSC also stocks the full next-generation GLP-1 class: Retatrutide (triple GLP-1R/GIPR/GCGR, Phase 2: −24.2%), Cagrilintide (AMY1R), Survodutide (GLP-1R/GCGR, NASH data), and Orforglipron (oral non-peptide GLP-1R). All for laboratory research only — not dispensed as prescription medications.
What GLP-1 compounds does QSC have that TrumpRx doesn’t offer?
TrumpRx offers clinically approved compounded semaglutide and tirzepatide. QSC stocks these plus pipeline compounds inaccessible through any clinical channel: Retatrutide (Phase 2: −24.2% at 48 weeks — the highest efficacy result in GLP-1 trial history), Orforglipron (first oral non-peptide GLP-1R agonist, Phase 3 ongoing), Cagrilintide (AMY1R/amylin analogue, CagriSema combination −15.6%), and Survodutide (dual GLP-1R/GCGR, Phase 2 NASH data). These are only accessible for research — no clinical platform can offer them.
Why do researchers use QSC instead of clinical platforms like TrumpRx?
Researchers studying GLP-1 receptor biology, incretin pharmacology, or metabolic mechanisms need research-grade verified compounds — not prescription medications. Clinical platforms like TrumpRx serve patients seeking treatment; QSC serves scientists studying the underlying biology. Critically, QSC stocks next-generation compounds (Retatrutide, Orforglipron, Cagrilintide) that are in Phase 2/3 trials but years from clinical approval — available for research use only through suppliers like QSC.
Is TrumpRx the same as Hims or Ro for GLP-1?
TrumpRx, Hims, Ro, and similar platforms are all US telehealth/compounding pharmacy services offering prescription GLP-1 medications (primarily compounded semaglutide and tirzepatide) via physician consultation. They operate in the same clinical category. QSC is a different category entirely — a research compound supplier for laboratory scientists, not a telehealth prescriber. For research access to GLP-1 compounds including unapproved pipeline molecules, QSC is the appropriate source.
What purity standard does QSC use for GLP-1 research compounds?
All QSC GLP-1 research compounds are verified at ≥99% HPLC purity with mass spectrometry molecular confirmation. Every batch carries a Janoshik independent COA — from a third-party laboratory with no commercial relationship with QSC — verifiable by any researcher at verify.janoshik.com using the unique batch code. This independent verification standard is distinct from pharmaceutical GMP (used by clinical compounders) and supplier-generated in-house COAs.
Research the Full GLP-1 Class — Including What TrumpRx Can’t Offer
Research Use Only: All products on qscpeptide.com are sold strictly for in vitro laboratory research purposes only. Not for human or veterinary use. QSC is not affiliated with TrumpRx. This page is an independent informational comparison. For clinical GLP-1 treatment, consult a licensed physician.
